Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06783868 · ClinicalTrials.gov registry record
Assessing the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control
A clinical trial, sponsored by Kansas City Heart Rhythm Research Foundation.
- Not yet
- Registry status
- 100
- Enrollment target
NCT06783868 is a clinical trial that has not yet begun recruiting, run by Kansas City Heart Rhythm Research Foundation. The registered enrollment target is 100 participants.
The verdict
NCT06783868 has not yet begun recruiting, sponsored by Kansas City Heart Rhythm Research Foundation.
- NOT YET RECRUITING
- Registry status
- 100 participants
- Enrollment target
Study Summary
A prospective, non-blinded, multi-center study to assess the impact of early Catheter Ablation (CA) in patients with a new diagnosis of Atrial Fibrillation(AF) at the time of stroke. 100 patients will be enrolled.
Interventions
- DEVICE Catheter Ablation
- DRUG Market-approved AVNB, OAC and AAD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-10 |
| Est. Completion | 2027-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06783868
The ClinicalTrials.gov registry entry for NCT06783868 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kansas City Heart Rhythm Research Foundation, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Catheter Ablation is the first listed.
NCT06783868 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06783868 about?
NCT06783868 is a clinical study titled "Assessing the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control". A prospective, non-blinded, multi-center study to assess the impact of early Catheter Ablation (CA) in patients with a new diagnosis of Atrial Fibrillation(AF) at the time of stroke. 100 patients will be enrolled.
What is the current status of trial NCT06783868?
This trial is currently not yet recruiting. The enrollment target is 100 participants. The study started on 2025-10. Estimated completion is 2027-06.
What interventions are being tested in trial NCT06783868?
The interventions under investigation include: Catheter Ablation (DEVICE), Market-approved AVNB, OAC and AAD (DRUG).
Who is sponsoring clinical trial NCT06783868?
This trial is sponsored by Kansas City Heart Rhythm Research Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.